Mergers & Acquisitions (M&A)

Pivotal Scientific are the market leaders in the research reagent market, supporting companies on all elements of their M&A across the UK, Europe, the Americas and Asia.

Our services cover company mergers, Acquisitions, disposals and Management buyouts (buy ins).

Our expertise has been developed from supporting companies across the industry over the past 6 years. We have also invested in expanding our specialist skills from other industries to ensure we provide our customers with the most comprehensive suite of services.

We believe the value we bring is the combination of deep industry knowledge with real experience in helping companies through a complex process.

Pivotal Scientific Limited’s Mergers & Acquisitions service include:

  1. Mergers & acquisition service from inception and assessment to completion and deal closure. This includes minority equity investment programmes.
  2. Feasibility studies for all variants of mergers and acquisitions including valuations
  3. Business plan creation, completion and modelling
  4. We will help to identify which companies are likely buyers and introduce them to you directly
  5. We will work closely with your company to identify businesses that will be a good strategic fit, communicate with them on your behalf and introduce them to you.

If you would like to download a printable PDF of this page please click here.

Pivotal Scientific Limited will provide a framework and model to support you through this process. We do not operate as legal or financial experts but purely as experts of Mergers & Acquisitions within the research reagent manufacturers’ arena.

Key

LOI – Letter of Indemnity              IOI – Indicator of Interest             HOA – Heads of Agreement         TBA – To be agreed

Monika Schermann

“PSL was a great partner when we decided to sell our company: Tim and James were extremely engaged in the whole process – which started with creating a company pack, getting in contact with potential buyers, starting a bidding process and going through the due diligence. Their experience in that field of business and their know-how, together with their network and of course also their great personality makes PSL to an unique and excellent consultancy.”

Monika Schermann
Tushendan Rasiah

CliniSciences has had a close relationship with Pivotal Scientific for many years and during that time we have seen them successfully partner a number of companies as part of their acquisitions service. When CliniSciences decided we wanted to acquire a distributor in the United Kingdom it was an easy decision to approach Pivotal Scientific to give us a detailed overview of the market. Pivotal then worked closely with us to identify companies that were within our target revenue range and approach them confidentially on our behalf. Once we had a shortlist we were introduced directly to the companies to continue the discussions.

In February of 2016 CliniSciences was able to finalise our acquisition of Generon. We have been extremely happy with the relationship we have developed with Generon and look forward to helping them grow over the coming years. We are very grateful to Pivotal Scientific to the support they gave to CliniSciences and we will definitely use them again.”

Tushendan RasiahCEO, Clinisciences
Hans-Joachim Soll

Acris Antibodies has been working with PSL and Tim Bernard for many years. In that time they have helped us in many ways, not the least in helping us to reorganize our distribution network and in mediating the merger of Acris Antibodies into the OriGene family just this year. PSL have done a really great job – thank you!

Hans-Joachim SollAcris Antibodies